Borrelia IgG Recombinant ELISA, 96 Wells

To add this product to your interest list, sign up or login.

Borrelia IgG Recombinant ELISA, 96 Wells

Manufacturer: DRG International Inc.
Model: Borrelia IgG recombinant ELISA, 96 wells
Product Code: EIA4289

Buy Now

If you want to buy the Borrelia IgG recombinant ELISA, 96 wells from a reliable laboratory equipment supplier, Block Scientific is the right company for you. Strategically situated in Bellport, New York, we have over 10 years of industry experience.

Enzyme Immunoassay

for Determination of igG Antibody

The Borrelia IgG recombinant ELISA, 96 wells is an enzyme immunoassay for the in-vitro semi-quantitative or quantitative determination of IgG antibodies against Borrelia burgdorferi in human serum, plasma and CSF.


  • Can detect infections with all three B. burgdorferi subspecies – garinii, afzelii and sensu strictu
  • Incubation time: 60/30/15 min


Borrelia burgdorferi, a bacterium of the Spirochaetaceae, is the ethiologic agent of Lyme disease (Borreliosis) being the most common disease in Europe and the USA transmitted by tics (Ixodes sp.). Lyme borreliosis is a multi-systemic disease with a broad spectrum of clinical symptoms. A typical symptom of the acute phase is the erythema chronicum migrans (ECM), often accompanied by flue-like symptoms. In later stages of the disease arthritis, carditis, as well as neurological and dermatological manifestations may occur. Lyme borreliosis can be treated with antibiotics in all stages. Therefore, a safe and sensitive laboratory diagnosis of Lyme borreliosis, also detecting the early stage of diseases, is of major importance, since an early treatment is most appreciated. IgM antibodies usually appear approximately three weeks after the infection, IgG antibodies after four to six weeks. The early immune reaction is mainly directed against the 14 kD region of the flagellin and the OspC (Outer surface protein C). Usually the acute phase is indicated by high titers of IgM antibodies. Elevated IgG titers with low or without IgM antibodies may occur when the borreliosis is subsiding (due to therapy or spontaneously) or during the chronic stage. The performance of the Borrelia IgG ELISA is important especially to detect a borreliosis even in cases showing negative 14 kD + OspC titers and to monitor the immune status. The Borrelia IgG ELISA employs the very highly specific recombinant Borrelia burgdorferi VlsE antigen and a highly specific crude lysate antigen blend from Borrelia burgdorferi sensu strictu, B. afzelii and B. garinii and therefore determines IgG antibodies with extremely high sensitivity and specificity.

To know more about how the Borrelia IgG recombinant ELISA, 96 wells and other infectious disease kits that may benefit your laboratory, dial 631-589-1118 or send an email to Continue browsing though our store to find other products that may be useful to you.